Hanne Fredly

Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents

Hanne Fredly, Bjørn Tore Gjertsen, Øystein Bruserud · Clinical Epigenetics · 2013 · 87 citations · Full text

Medicine, Oncology, Pharmacology +17

The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia

Hanne Fredly, Elisabeth Ersvær, Astrid Olsnes Kittang et al. · Clinical Epigenetics · 2013 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Disease‐stabilizing treatment with all‐trans retinoic acid and valproic acid in acute myeloid leukemia: Serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti‐leukemic treatment

Hanne Fredly, Håkon Reikvam, Bjørn Tore Gjertsen et al. · American Journal of Hematology · 2012 · 42 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia

Ingvild Haaland, Jill A. Opsahl, Frode S. Berven et al. · Molecular Cancer · 2014 · 36 citations · Full text

Medicine, Oncology, Pharmacology +11

Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy

Ida Sofie Grønningsæter, Hanne Fredly, Bjørn Tore Gjertsen et al. · Cells · 2019 · 29 citations · Full text

Life Sciences, Oncology, Pharmacology +17